CH
Cochlear Limited
CHEOY · OTC
$48.12 -1.57% (-$0.77)
1M +2.56%
Market Cap $8.94B
P/E Ratio 60.68x
Div. Yield 2.97%
ROE 7.86%
Bulios Fair Price
$29.61
38.5% downside
Current Price
$48.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHEOY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
20 /100
Expensive P/E 60.68x
P/B 5.14x
EV/EBITDA 27.02x
Growth
40 /100
Stable Rev. growth 6.28%
Book val. growth 0.16%
FCF growth 1.33%
Profitability
62 /100
Moderate Gross margin 70.69%
FCF margin 11.81%
Net margin 6.27%
Quality
45 /100
Average ROIC 7.06%
Asset turnover 0.90x
ROE 7.86%
Debt
100 /100
Low Debt/Equity 0.12x
Net debt/EBITDA 0.08x
Current ratio 2.15x
Stability
54 /100
Moderate Beta 0.26x
Profitable years 6
Rev. volatility 7.20%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHEOY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Diggory William Howitt
Employees
5,400
Headquarters
Sydney
Upcoming events
22 SEP
Ex-Dividend
Ex-dividend date
03 NOV
Dividend Payment
Payment date